Last night, Choate received the Life Sciences IP Firm of the Year award at the Life Sciences Patent Network (LSPN) 2026 Awards Gala. The firm also earned the “Highly Commended” ranking for the Life Sciences Patent Strategy Firm of the Year award. The LSPN awards recognize firms for excellence, innovation, and leadership in life sciences IP – recipients are among the most highly regarded law firms in the country for their work in IP. Award nominees are evaluated by a panel of industry experts utilizing a two-stage process to ensure that winners are selected through both objective evaluation and thoughtful peer discussion. For more than four decades, Choate has served as trusted intellectual property counsel to leading pharmaceutical and biotech companies, technology companies, and investors – representing clients throughout their life cycle from startup to maturity. Our team of IP attorneys, patent agents, and scientists (including more than 45 with PhDs and other advanced degrees from leading institutions) are experts in more than 20 technology areas. Similarly, our IP litigators are seasoned trial lawyers who understand the critical role of enforcing and defending IP rights. In addition to LSPN, Choate and its partners have been recognized in several IP rankings including by Chambers USA, Legal 500, Best Lawyers, LMG Life Sciences, Managing Intellectual Property, IAM Patent 1000, and Benchmark Litigation.